Statistics for OSE Immuno (id:10902 OSE)
Valuation metrics
Market cap
193.89M
Enterprise value
161.58M
Trailing P/E (ttm)
5.14
Forward P/E
7.41
PEG ratio
7.41
Price/Sales (ttm)
2.32
Price/Book (mrq)
2.38
Enterprise Value/Revenue
1.94
Enterprise Value/EBITDA
3.05
Overview
Shares outstanding
21.81M
Float
16.33M
Shares short
% Held by insiders
0.27%
% Held by institutions
0.03%
Average volume (10 days)
110.82K
Average volume (90 days)
Price summary
52-Week low
3.12
52-Week high
11.58
52-Week change
55.92%
Beta
0.81
50-Day moving average
9.07
200-Day moving average
6.99
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
55.17%
Operating margin
76.68%
Operational effectiveness
Return on assets
30.41%
Return on equity
88.54%
Income statement
Revenue (ttm)
3.95
Revenue per share (ttm)
3.95
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
52.96M
Net income to common (ttm)
46.03M
Diluted EPS (ttm)
1.73
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
75.75M
Total cash per share (mrq)
3.48
Total debt (mrq)
43.88M
Total Debt/Equity (mrq)
53.88
Current ratio (mrq)
493.40%
Book value per share (mrq)
3.74
Cash flow
Cash flow statement
58.36M
Levered free cash flow (LFCF)
40.61M